Prevention and management of graft thrombosis in pancreatic transplant.
Pancreatic transplant effectively cures type 1 diabetes mellitus and maintains consistent long-term euglycemia. However, technical failure, and in particular graft thrombosis, accounts for the vast majority of transplants lost in the early postoperative period. The pancreas' inherently low microvascular flow state makes it vulnerable to vascular complications, as does the hypercoagulable blood of diabetic patients. Ultimately, the phenomenon is most definitely multifactorial. Prevention, as opposed to treatment, is key and should focus on reducing these multiple risk factors. This will involve tactical donor selection, optimal surgical technique and some form of anticoagulation. Close monitoring and early intervention will be crucial when treating thrombosis once preventative methods have failed. This may be achieved by further anticoagulation, graft salvage, or pancreatectomy with retransplant. This article will explore the multiple factors contributing to graft thrombus formation and the ways in which they may be addressed to firstly prevent, or more likely, reduce thrombosis. Secondly, we will consider the management strategies which can be implemented once thrombosis has occurred.
The West London Renal and Transplant Centre, Imperial College Healthcare NHS Trust, London, United Kingdom.
Shaneel R
SR
Patel
Nadey
N
Hakim
D000925:Anticoagulants / Q000627:therapeutic use*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D019468:Disease Management; D046148:Donor Selection; D061345:Early Medical Intervention; D006083:Graft Occlusion, Vascular / Q000517:prevention & control* / Q000628:therapy*; D006801:Humans; D016035:Pancreas Transplantation / Q000379:methods / Q000592:standards*; D010180:Pancreatectomy; D012086:Reoperation; D016879:Salvage Therapy; D013927:Thrombosis / Q000517:prevention & control* / Q000628:therapy*
D000925:Anticoagulants